Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this randomized, double-blind study is to compare parenteral pre-emptive oxycodone, morphine and dexamethasone with placebo in the treatment of postoperative pain in paediatric patients 4 to 12 years of age. The investigators hope to find out whether there are any differences in postoperative pain and/or adverse effects among these groups.
After the induction of anaesthesia and before intubation the child receives one of the research drugs in a double-blind fashion: 0.1 mg/kg of oxycodone , 0.1 mg/kg of morphine, 0.5 mg/kg dexamethasone (max 24 mg), or placebo. All the research drugs are diluted into a dose of 10 ml with NaCl 0.9%, the placebo being solely the dilute.
The patients are followed minimum 4h postoperatively: first in the recovery room, and after the patient is stable enough the study is continued in the day-patient unit. Level of pain and adverse effects are registered all on same predetermined intervals being 15 min during the first postoperative hour, followed by interval of 30 min until the discharge.
The safety measurements noted include pulse, respiratory rate, non-invasive blood pressure and peripheral oxygen saturation are recorded on the same intervals The registering of pain, adverse effects and given medication continues at home for 48 hours post operatively with a questionnaire filled by the parents.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Active Comparator | 0,1 mg/kg of oxycodone |
|
| 2 | Active Comparator | 0,1 mg/kg of morphine |
|
| 3 | Active Comparator | 0,5 mg/kg dexamethasone (max 24 mg |
|
| 4 | Placebo Comparator | NaCl 0,9% |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 0,1 mg/kg of oxycodone | Drug | solution for injection, 0,1 mg/kg, one injection in the beginning of anesthesia |
|
| Measure | Description | Time Frame |
|---|---|---|
| The difference of needed rescue pain medication post operatively | predetermined intervals being 15 min during the first postoperative hour, followed by interval of 30 min for 4 first postop hours. At home pain and adverse effects are registered by parent at 24 hours and 48 hours. |
| Measure | Description | Time Frame |
|---|---|---|
| differences in adverse effects | In hospital 4 hours with first hour in 15 min intervals, then 30 min. At home 24+48h |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Mari S Aallos-Ravenna, MD | Contact | +35823130655 | mari.aallos-ravenna@tyks.fi | |
| Tuula Manner, MD | Contact | +35823130962 | tuula.manner@tyks.fi |
| Name | Affiliation | Role |
|---|---|---|
| Tuula Manner, MD, PhD | Turku University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Turku University hospital | Turku | Finland |
Not provided
Not provided
Not provided
Not provided
Not provided
| Morphine 0,1 mg/kg | Drug | solution for injection, 0,1 mg/kg, one injection in the beginning of anesthesia |
|
|
| Dexamethasone 0,5 mg/kg | Drug | solution for injection, 0,5 mg/kg, one injection in the beginning of anesthesia |
|
|
| NaCl 0,9% | Drug | solution for injection one injection in the beginning of anesthesia |
|
|
| ID | Term |
|---|---|
| D010146 | Pain |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D009020 | Morphine |
| D003907 | Dexamethasone |
| ID | Term |
|---|---|
| D009022 | Morphine Derivatives |
| D009019 | Morphinans |
| D053610 | Opiate Alkaloids |
| D000470 | Alkaloids |
| D006571 | Heterocyclic Compounds |
| D006572 | Heterocyclic Compounds, Bridged-Ring |
| D006576 | Heterocyclic Compounds, 4 or More Rings |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D010616 | Phenanthrenes |
| D011084 | Polycyclic Aromatic Hydrocarbons |
| D011083 | Polycyclic Compounds |
| D011246 | Pregnadienetriols |
| D011245 | Pregnadienes |
| D011278 | Pregnanes |
| D013256 | Steroids |
| D000072473 | Fused-Ring Compounds |
| D013259 | Steroids, Fluorinated |
Not provided
Not provided